Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114315563B reveals a regioselective hydrocarboxylation method using PdCl2 and formic acid. This process offers significant cost reduction and supply chain reliability for fine chemical intermediates.
Novel axial chiral phosphine catalyst synthesis via chiral phosphoric acid. High ee, mild conditions. Ideal for asymmetric hydrosilylation and coupling. Reliable supplier for pharma intermediates.
Patent CN117430549A details a green copper-catalyzed method for isonicotinic acid using CO2. Offers mild conditions and supply chain advantages for pharma intermediates.
Patent CN113620795B details a Rh-catalyzed C-H activation route to benzocycloheptenones. This method offers mild conditions, high yields, and scalable production for pharmaceutical intermediates.
Patent CN105111228A reveals a novel 5,5'-tetralone chiral phosphoric acid with superior acidity and enantioselectivity for cost-effective pharmaceutical intermediate manufacturing.
Patent CN112094220B reveals a copper-catalyzed route for high-purity indole sulfones, enabling cost-effective API intermediate manufacturing and streamlined supply chains.
Patent CN111848322B details a novel organocatalytic resolution for axially chiral styrenes. Discover cost-effective, high-ee synthetic routes for pharmaceutical intermediates.
Patent CN112209947A discloses a mild, high-yield organocatalytic route to chiral indoxazinones with potent anticancer activity, offering significant cost reduction in API manufacturing.
Patent CN110156658A reveals efficient chiral phosphoric acid catalysis for triarylmethane derivatives ensuring high purity and scalable supply chain solutions.
Novel chiral phosphoric acid catalysis enables high-yield antitumor intermediate production with simplified supply chain and significant cost efficiency for global pharmaceutical partners.
Patent CN102766092A reveals a mild, high-enantioselectivity route for tetrahydroquinolines, offering significant cost and supply chain advantages for pharmaceutical manufacturers.
Novel chiral phosphoric acid catalysis for indoline pyrroles ensures high ee and mild conditions. We are a reliable supplier for pharmaceutical intermediates offering significant cost reduction and scalable production capabilities for global partners.
Patent CN106748966B reveals a cost-effective route for high-purity pharmaceutical intermediates. Enhance supply chain reliability with scalable manufacturing solutions.
Novel indolocyclopentanes synthesis via chiral phosphoric acid. High yield, mild conditions. Reliable pharmaceutical intermediates supplier for anticancer drug development.
Novel chiral phosphoric acid catalyzed synthesis offers high enantioselectivity and yield for antitumor drug intermediates, ensuring supply chain stability.
Novel organocatalytic method for high-purity axial chiral indole-naphthalenes. Efficient scale-up and cost-effective production for asymmetric catalysis applications.
Green synthesis of polysubstituted nicotinic acid esters via acidic ionic liquid catalysis. Offers cost reduction and high purity for pharmaceutical intermediate manufacturing.
Patent CN110156658A reveals a novel chiral phosphoric acid catalyzed route offering high enantioselectivity and substantial cost reduction in pharma manufacturing supply chains.
Novel synthesis route for Sulpiride intermediate. Mild conditions, high purity. Reliable pharmaceutical intermediate supplier for global supply chains.
Patent CN108558635B details a catalyst-free carboxylation method for high-purity 3-arylpropynoic acids, offering significant cost reduction in fine chemical manufacturing.